CVS will sell a generic version of Impax Laboratories’ Adrenaclick treatment for $109.99 per two-pack, down from $200. In comparison, Mylan’s generic epinephrine auto-injector cost $300 for a two-pack, about 50 percent less than EpiPen’s $608 list price. Mylan announced it would be releasing the generic device in December after taking widespread criticism for raising its price for EpiPen by more than 400 percent since 2009.
In other Mylan news, Bloomfield, Conn.-based health insurer Cigna announced it is dropping coverage for Mylan’s EpiPen and EpiPen Jr. auto-injectors in favor of its generic alternative, according to the payer’s prescription drug list changes.
More articles on supply chain:
7 must-reads for supply chain leaders this week
Op-ed: The 1 way pharma can get on Trump’s good side
Implanted abdominal pumps may malfunction in MRIs, FDA warns
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.